nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproheptadine—HTR2A—autistic disorder	0.523	1	CbGaD
Cyproheptadine—HTR2C—telencephalic ventricle—autistic disorder	0.00894	0.0529	CbGeAlD
Cyproheptadine—HTR2A—cerebellar cortex—autistic disorder	0.00771	0.0456	CbGeAlD
Cyproheptadine—HTR1A—telencephalic ventricle—autistic disorder	0.00753	0.0446	CbGeAlD
Cyproheptadine—DRD2—telencephalic ventricle—autistic disorder	0.0068	0.0403	CbGeAlD
Cyproheptadine—HTR2A—pons—autistic disorder	0.00545	0.0323	CbGeAlD
Cyproheptadine—UGT1A3—digestive system—autistic disorder	0.00487	0.0288	CbGeAlD
Cyproheptadine—HTR2A—telencephalic ventricle—autistic disorder	0.00449	0.0266	CbGeAlD
Cyproheptadine—HTR6—forebrain—autistic disorder	0.00404	0.0239	CbGeAlD
Cyproheptadine—HTR6—telencephalon—autistic disorder	0.00372	0.022	CbGeAlD
Cyproheptadine—HTR1A—hindbrain—autistic disorder	0.00355	0.021	CbGeAlD
Cyproheptadine—DRD2—hindbrain—autistic disorder	0.00321	0.019	CbGeAlD
Cyproheptadine—CHRM2—forebrain—autistic disorder	0.00242	0.0143	CbGeAlD
Cyproheptadine—HTR2C—brainstem—autistic disorder	0.00242	0.0143	CbGeAlD
Cyproheptadine—HTR2C—forebrain—autistic disorder	0.00234	0.0138	CbGeAlD
Cyproheptadine—HTR6—head—autistic disorder	0.00231	0.0137	CbGeAlD
Cyproheptadine—CHRM2—telencephalon—autistic disorder	0.00223	0.0132	CbGeAlD
Cyproheptadine—CHRM1—forebrain—autistic disorder	0.00221	0.0131	CbGeAlD
Cyproheptadine—HTR6—nervous system—autistic disorder	0.00219	0.013	CbGeAlD
Cyproheptadine—HTR2B—forebrain—autistic disorder	0.00219	0.013	CbGeAlD
Cyproheptadine—HTR2C—telencephalon—autistic disorder	0.00215	0.0127	CbGeAlD
Cyproheptadine—HTR2A—hindbrain—autistic disorder	0.00212	0.0125	CbGeAlD
Cyproheptadine—HTR6—central nervous system—autistic disorder	0.00211	0.0125	CbGeAlD
Cyproheptadine—HTR1A—brainstem—autistic disorder	0.00204	0.0121	CbGeAlD
Cyproheptadine—CHRM1—telencephalon—autistic disorder	0.00203	0.012	CbGeAlD
Cyproheptadine—SLC6A2—brainstem—autistic disorder	0.00202	0.012	CbGeAlD
Cyproheptadine—HTR2B—telencephalon—autistic disorder	0.00202	0.0119	CbGeAlD
Cyproheptadine—CHRM3—forebrain—autistic disorder	0.00197	0.0117	CbGeAlD
Cyproheptadine—HTR1A—forebrain—autistic disorder	0.00197	0.0116	CbGeAlD
Cyproheptadine—SLC6A2—forebrain—autistic disorder	0.00195	0.0115	CbGeAlD
Cyproheptadine—DRD2—brainstem—autistic disorder	0.00184	0.0109	CbGeAlD
Cyproheptadine—CHRM3—telencephalon—autistic disorder	0.00182	0.0107	CbGeAlD
Cyproheptadine—HTR1A—telencephalon—autistic disorder	0.00181	0.0107	CbGeAlD
Cyproheptadine—SLC6A2—telencephalon—autistic disorder	0.00179	0.0106	CbGeAlD
Cyproheptadine—DRD2—eye—autistic disorder	0.00179	0.0106	CbGeAlD
Cyproheptadine—DRD2—forebrain—autistic disorder	0.00178	0.0105	CbGeAlD
Cyproheptadine—Loxapine—HTR5A—autistic disorder	0.00171	0.129	CrCbGaD
Cyproheptadine—HTR6—brain—autistic disorder	0.00168	0.00993	CbGeAlD
Cyproheptadine—Ketotifen—PDE4A—autistic disorder	0.00164	0.124	CrCbGaD
Cyproheptadine—DRD2—telencephalon—autistic disorder	0.00163	0.00967	CbGeAlD
Cyproheptadine—HTR2B—digestive system—autistic disorder	0.00154	0.00911	CbGeAlD
Cyproheptadine—HRH1—eye—autistic disorder	0.00142	0.00837	CbGeAlD
Cyproheptadine—HRH1—forebrain—autistic disorder	0.0014	0.0083	CbGeAlD
Cyproheptadine—CHRM2—head—autistic disorder	0.00139	0.00821	CbGeAlD
Cyproheptadine—CHRM3—digestive system—autistic disorder	0.00139	0.0082	CbGeAlD
Cyproheptadine—Ketotifen—PDE4B—autistic disorder	0.00136	0.103	CrCbGaD
Cyproheptadine—HTR2C—head—autistic disorder	0.00134	0.00791	CbGeAlD
Cyproheptadine—CHRM2—nervous system—autistic disorder	0.00132	0.00779	CbGeAlD
Cyproheptadine—HRH1—telencephalon—autistic disorder	0.00129	0.00763	CbGeAlD
Cyproheptadine—HTR2C—nervous system—autistic disorder	0.00127	0.0075	CbGeAlD
Cyproheptadine—CHRM2—central nervous system—autistic disorder	0.00127	0.0075	CbGeAlD
Cyproheptadine—CHRM1—head—autistic disorder	0.00126	0.00747	CbGeAlD
Cyproheptadine—HTR2B—head—autistic disorder	0.00126	0.00744	CbGeAlD
Cyproheptadine—HTR2C—central nervous system—autistic disorder	0.00122	0.00722	CbGeAlD
Cyproheptadine—HTR2A—brainstem—autistic disorder	0.00121	0.00718	CbGeAlD
Cyproheptadine—CHRM1—nervous system—autistic disorder	0.0012	0.00709	CbGeAlD
Cyproheptadine—HTR2B—nervous system—autistic disorder	0.00119	0.00705	CbGeAlD
Cyproheptadine—HTR2A—eye—autistic disorder	0.00118	0.00699	CbGeAlD
Cyproheptadine—HTR2A—forebrain—autistic disorder	0.00117	0.00693	CbGeAlD
Cyproheptadine—CHRM1—central nervous system—autistic disorder	0.00115	0.00682	CbGeAlD
Cyproheptadine—HTR2B—central nervous system—autistic disorder	0.00115	0.00679	CbGeAlD
Cyproheptadine—CHRM3—head—autistic disorder	0.00113	0.00669	CbGeAlD
Cyproheptadine—HTR1A—head—autistic disorder	0.00113	0.00666	CbGeAlD
Cyproheptadine—SLC6A2—head—autistic disorder	0.00112	0.00661	CbGeAlD
Cyproheptadine—HTR2A—telencephalon—autistic disorder	0.00108	0.00638	CbGeAlD
Cyproheptadine—CHRM3—nervous system—autistic disorder	0.00107	0.00634	CbGeAlD
Cyproheptadine—HTR1A—nervous system—autistic disorder	0.00107	0.00632	CbGeAlD
Cyproheptadine—SLC6A2—nervous system—autistic disorder	0.00106	0.00626	CbGeAlD
Cyproheptadine—CHRM3—central nervous system—autistic disorder	0.00103	0.00611	CbGeAlD
Cyproheptadine—HTR1A—central nervous system—autistic disorder	0.00103	0.00608	CbGeAlD
Cyproheptadine—SLC6A2—central nervous system—autistic disorder	0.00102	0.00603	CbGeAlD
Cyproheptadine—DRD2—head—autistic disorder	0.00102	0.00602	CbGeAlD
Cyproheptadine—CHRM2—brain—autistic disorder	0.00101	0.00595	CbGeAlD
Cyproheptadine—HTR1A—cerebellum—autistic disorder	0.001	0.00594	CbGeAlD
Cyproheptadine—HRH1—digestive system—autistic disorder	0.000985	0.00583	CbGeAlD
Cyproheptadine—HTR2C—brain—autistic disorder	0.000969	0.00574	CbGeAlD
Cyproheptadine—DRD2—nervous system—autistic disorder	0.000964	0.00571	CbGeAlD
Cyproheptadine—DRD2—central nervous system—autistic disorder	0.000928	0.00549	CbGeAlD
Cyproheptadine—CHRM1—brain—autistic disorder	0.000915	0.00542	CbGeAlD
Cyproheptadine—HTR2B—brain—autistic disorder	0.00091	0.00539	CbGeAlD
Cyproheptadine—DRD2—cerebellum—autistic disorder	0.000908	0.00537	CbGeAlD
Cyproheptadine—Amitriptyline—NTRK2—autistic disorder	0.000859	0.0649	CrCbGaD
Cyproheptadine—HTR2A—digestive system—autistic disorder	0.000822	0.00487	CbGeAlD
Cyproheptadine—CHRM3—brain—autistic disorder	0.000819	0.00485	CbGeAlD
Cyproheptadine—HTR1A—brain—autistic disorder	0.000816	0.00483	CbGeAlD
Cyproheptadine—SLC6A2—brain—autistic disorder	0.000809	0.00479	CbGeAlD
Cyproheptadine—HRH1—head—autistic disorder	0.000803	0.00475	CbGeAlD
Cyproheptadine—HRH1—nervous system—autistic disorder	0.000762	0.00451	CbGeAlD
Cyproheptadine—DRD2—brain—autistic disorder	0.000737	0.00436	CbGeAlD
Cyproheptadine—HRH1—central nervous system—autistic disorder	0.000733	0.00434	CbGeAlD
Cyproheptadine—HTR2A—head—autistic disorder	0.000671	0.00397	CbGeAlD
Cyproheptadine—HTR2A—nervous system—autistic disorder	0.000636	0.00376	CbGeAlD
Cyproheptadine—HTR2A—central nervous system—autistic disorder	0.000612	0.00362	CbGeAlD
Cyproheptadine—HTR2A—cerebellum—autistic disorder	0.000599	0.00354	CbGeAlD
Cyproheptadine—Mianserin—HTR1D—autistic disorder	0.000596	0.0451	CrCbGaD
Cyproheptadine—HRH1—brain—autistic disorder	0.000582	0.00344	CbGeAlD
Cyproheptadine—Protriptyline—SLC6A4—autistic disorder	0.000557	0.0421	CrCbGaD
Cyproheptadine—HTR2A—brain—autistic disorder	0.000486	0.00288	CbGeAlD
Cyproheptadine—Loxapine—HTR3A—autistic disorder	0.000479	0.0362	CrCbGaD
Cyproheptadine—Loxapine—HTR1D—autistic disorder	0.000474	0.0358	CrCbGaD
Cyproheptadine—Clozapine—HTR3A—autistic disorder	0.000402	0.0304	CrCbGaD
Cyproheptadine—Clozapine—HTR1D—autistic disorder	0.000398	0.0301	CrCbGaD
Cyproheptadine—Amitriptyline—HTR1D—autistic disorder	0.00037	0.0279	CrCbGaD
Cyproheptadine—Mianserin—DRD3—autistic disorder	0.000343	0.0259	CrCbGaD
Cyproheptadine—Cyclobenzaprine—HTR2A—autistic disorder	0.00032	0.0242	CrCbGaD
Cyproheptadine—Loxapine—HTR1B—autistic disorder	0.000281	0.0212	CrCbGaD
Cyproheptadine—Loxapine—DRD3—autistic disorder	0.000273	0.0206	CrCbGaD
Cyproheptadine—Amitriptyline—OPRM1—autistic disorder	0.000269	0.0203	CrCbGaD
Cyproheptadine—Loxapine—DRD1—autistic disorder	0.000268	0.0202	CrCbGaD
Cyproheptadine—Mianserin—SLC6A4—autistic disorder	0.000239	0.0181	CrCbGaD
Cyproheptadine—Clozapine—HTR1B—autistic disorder	0.000236	0.0178	CrCbGaD
Cyproheptadine—Clozapine—DRD3—autistic disorder	0.000229	0.0173	CrCbGaD
Cyproheptadine—Clozapine—DRD1—autistic disorder	0.000225	0.017	CrCbGaD
Cyproheptadine—Amitriptyline—HTR1B—autistic disorder	0.000219	0.0166	CrCbGaD
Cyproheptadine—Nortriptyline—SLC6A4—autistic disorder	0.000214	0.0161	CrCbGaD
Cyproheptadine—Amitriptyline—DRD3—autistic disorder	0.000213	0.0161	CrCbGaD
Cyproheptadine—Loxapine—SLC6A4—autistic disorder	0.00019	0.0143	CrCbGaD
Cyproheptadine—Mianserin—HTR2A—autistic disorder	0.000184	0.0139	CrCbGaD
Cyproheptadine—Nortriptyline—HTR2A—autistic disorder	0.000164	0.0124	CrCbGaD
Cyproheptadine—Amitriptyline—SLC6A4—autistic disorder	0.000148	0.0112	CrCbGaD
Cyproheptadine—Loxapine—HTR2A—autistic disorder	0.000146	0.011	CrCbGaD
Cyproheptadine—Clozapine—HTR2A—autistic disorder	0.000122	0.00926	CrCbGaD
Cyproheptadine—Amitriptyline—HTR2A—autistic disorder	0.000114	0.00861	CrCbGaD
Cyproheptadine—CHRM2—Signaling by GPCR—POMC—autistic disorder	1.54e-05	5.22e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—LEP—autistic disorder	1.54e-05	5.22e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—APOE—autistic disorder	1.54e-05	5.22e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PRL—autistic disorder	1.54e-05	5.21e-05	CbGpPWpGaD
Cyproheptadine—UGT1A3—Metabolism—PTEN—autistic disorder	1.53e-05	5.19e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—APC—autistic disorder	1.52e-05	5.16e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—PIK3CG—autistic disorder	1.52e-05	5.16e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—PLA2G4A—autistic disorder	1.52e-05	5.15e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—PLA2G4A—autistic disorder	1.51e-05	5.12e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—ADRB2—autistic disorder	1.51e-05	5.12e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—EGF—autistic disorder	1.5e-05	5.1e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—GPX1—autistic disorder	1.49e-05	5.05e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—ADRB2—autistic disorder	1.48e-05	5.03e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—ADRB2—autistic disorder	1.48e-05	5.02e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—IL2—autistic disorder	1.48e-05	5.01e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—ADRB2—autistic disorder	1.48e-05	5.01e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MEF2C—autistic disorder	1.48e-05	5.01e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—ADRB2—autistic disorder	1.47e-05	4.99e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—IL2—autistic disorder	1.47e-05	4.99e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MEF2C—autistic disorder	1.47e-05	4.98e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—ADRB2—autistic disorder	1.46e-05	4.94e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—PRKCB—autistic disorder	1.45e-05	4.92e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—POMC—autistic disorder	1.45e-05	4.91e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—ITGB3—autistic disorder	1.44e-05	4.88e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—ITGB3—autistic disorder	1.43e-05	4.85e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—AVP—autistic disorder	1.42e-05	4.81e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IGF2—autistic disorder	1.41e-05	4.78e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—AVP—autistic disorder	1.39e-05	4.73e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—IGF1—autistic disorder	1.39e-05	4.73e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—AVP—autistic disorder	1.39e-05	4.72e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—PIK3CG—autistic disorder	1.39e-05	4.71e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—APC—autistic disorder	1.39e-05	4.71e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IGF2—autistic disorder	1.39e-05	4.71e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—MAPK1—autistic disorder	1.39e-05	4.7e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—AVP—autistic disorder	1.39e-05	4.7e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IGF2—autistic disorder	1.38e-05	4.7e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—AVP—autistic disorder	1.38e-05	4.69e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IGF2—autistic disorder	1.38e-05	4.68e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IGF2—autistic disorder	1.38e-05	4.67e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—MTHFR—autistic disorder	1.37e-05	4.66e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—EGF—autistic disorder	1.37e-05	4.66e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—AVP—autistic disorder	1.37e-05	4.64e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IGF2—autistic disorder	1.36e-05	4.62e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—HTR2A—autistic disorder	1.34e-05	4.55e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—IL2—autistic disorder	1.34e-05	4.55e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—HTR2A—autistic disorder	1.34e-05	4.53e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—IL2—autistic disorder	1.33e-05	4.53e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PLA2G4A—autistic disorder	1.33e-05	4.52e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—SERPINE1—autistic disorder	1.32e-05	4.49e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—POMC—autistic disorder	1.32e-05	4.49e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PLA2G4A—autistic disorder	1.31e-05	4.45e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PLA2G4A—autistic disorder	1.31e-05	4.44e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PLA2G4A—autistic disorder	1.3e-05	4.42e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PLA2G4A—autistic disorder	1.3e-05	4.41e-05	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—IL2—autistic disorder	1.3e-05	4.4e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MEF2C—autistic disorder	1.3e-05	4.4e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PLA2G4A—autistic disorder	1.29e-05	4.37e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—APOE—autistic disorder	1.28e-05	4.34e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—IL2—autistic disorder	1.28e-05	4.33e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—TSC2—autistic disorder	1.28e-05	4.33e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MEF2C—autistic disorder	1.27e-05	4.33e-05	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—IL2—autistic disorder	1.27e-05	4.32e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MEF2C—autistic disorder	1.27e-05	4.32e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—IGF1—autistic disorder	1.27e-05	4.31e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—IL2—autistic disorder	1.27e-05	4.31e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—TSC2—autistic disorder	1.27e-05	4.3e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MEF2C—autistic disorder	1.27e-05	4.3e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—MAPK1—autistic disorder	1.27e-05	4.29e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—IL2—autistic disorder	1.27e-05	4.29e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MEF2C—autistic disorder	1.26e-05	4.29e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—ITGB3—autistic disorder	1.26e-05	4.28e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—IL2—autistic disorder	1.25e-05	4.25e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MEF2C—autistic disorder	1.25e-05	4.25e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—LEP—autistic disorder	1.25e-05	4.23e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—APOE—autistic disorder	1.25e-05	4.23e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—ITGB3—autistic disorder	1.24e-05	4.21e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—APOE—autistic disorder	1.24e-05	4.21e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—LEP—autistic disorder	1.24e-05	4.21e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—ITGB3—autistic disorder	1.24e-05	4.21e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—ITGB3—autistic disorder	1.24e-05	4.19e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—ITGB3—autistic disorder	1.23e-05	4.18e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—ITGB3—autistic disorder	1.22e-05	4.14e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—SERPINE1—autistic disorder	1.21e-05	4.1e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—HTR2A—autistic disorder	1.18e-05	4e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—IL2—autistic disorder	1.18e-05	4e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—PRKCB—autistic disorder	1.18e-05	3.99e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—PRKCB—autistic disorder	1.17e-05	3.97e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—IL2—autistic disorder	1.16e-05	3.93e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—HTR2A—autistic disorder	1.16e-05	3.93e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—IL2—autistic disorder	1.16e-05	3.92e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PIK3CG—autistic disorder	1.15e-05	3.91e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—HTR2A—autistic disorder	1.15e-05	3.91e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—IL2—autistic disorder	1.15e-05	3.91e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—HTR2A—autistic disorder	1.15e-05	3.9e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—IL2—autistic disorder	1.15e-05	3.9e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—HTR2A—autistic disorder	1.14e-05	3.86e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—IL2—autistic disorder	1.14e-05	3.86e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—APC—autistic disorder	1.13e-05	3.82e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—PIK3CG—autistic disorder	1.13e-05	3.82e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—PIK3CG—autistic disorder	1.12e-05	3.8e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—APC—autistic disorder	1.12e-05	3.8e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—TSC2—autistic disorder	1.12e-05	3.8e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—EGF—autistic disorder	1.11e-05	3.78e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—HRAS—autistic disorder	1.11e-05	3.78e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—EGF—autistic disorder	1.11e-05	3.76e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—TSC2—autistic disorder	1.1e-05	3.74e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—TSC2—autistic disorder	1.1e-05	3.73e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—POMC—autistic disorder	1.1e-05	3.73e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—TSC2—autistic disorder	1.1e-05	3.72e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—APOE—autistic disorder	1.1e-05	3.72e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—LEP—autistic disorder	1.1e-05	3.72e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—TSC2—autistic disorder	1.09e-05	3.71e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—TSC2—autistic disorder	1.08e-05	3.67e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—LEP—autistic disorder	1.08e-05	3.66e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—APOE—autistic disorder	1.08e-05	3.66e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—LEP—autistic disorder	1.08e-05	3.65e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—APOE—autistic disorder	1.08e-05	3.65e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—LEP—autistic disorder	1.07e-05	3.64e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—APOE—autistic disorder	1.07e-05	3.64e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—POMC—autistic disorder	1.07e-05	3.64e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—IL2—autistic disorder	1.07e-05	3.63e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—LEP—autistic disorder	1.07e-05	3.63e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—APOE—autistic disorder	1.07e-05	3.63e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—POMC—autistic disorder	1.07e-05	3.62e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—IL6—autistic disorder	1.07e-05	3.61e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—APOE—autistic disorder	1.06e-05	3.59e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—LEP—autistic disorder	1.06e-05	3.59e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PRKCB—autistic disorder	1.03e-05	3.51e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—IGF1—autistic disorder	1.03e-05	3.5e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—MAPK1—autistic disorder	1.03e-05	3.48e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—IGF1—autistic disorder	1.03e-05	3.48e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—MAPK1—autistic disorder	1.02e-05	3.46e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PRKCB—autistic disorder	1.02e-05	3.45e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—HRAS—autistic disorder	1.02e-05	3.45e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PRKCB—autistic disorder	1.01e-05	3.44e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PRKCB—autistic disorder	1.01e-05	3.43e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PRKCB—autistic disorder	1.01e-05	3.42e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—PTEN—autistic disorder	1.01e-05	3.42e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PRKCB—autistic disorder	9.98e-06	3.39e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PIK3CG—autistic disorder	9.89e-06	3.36e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—APC—autistic disorder	9.89e-06	3.36e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—SERPINE1—autistic disorder	9.79e-06	3.32e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—EGF—autistic disorder	9.78e-06	3.32e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—IL2—autistic disorder	9.77e-06	3.32e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—SERPINE1—autistic disorder	9.74e-06	3.31e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—APC—autistic disorder	9.73e-06	3.3e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PIK3CG—autistic disorder	9.73e-06	3.3e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—IL6—autistic disorder	9.73e-06	3.3e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—APC—autistic disorder	9.71e-06	3.29e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PIK3CG—autistic disorder	9.71e-06	3.29e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PIK3CG—autistic disorder	9.68e-06	3.28e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—APC—autistic disorder	9.68e-06	3.28e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PIK3CG—autistic disorder	9.65e-06	3.27e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—APC—autistic disorder	9.65e-06	3.27e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—EGF—autistic disorder	9.62e-06	3.26e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—EGF—autistic disorder	9.6e-06	3.26e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—EGF—autistic disorder	9.57e-06	3.25e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PIK3CG—autistic disorder	9.55e-06	3.24e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—APC—autistic disorder	9.55e-06	3.24e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—EGF—autistic disorder	9.54e-06	3.24e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—EGF—autistic disorder	9.44e-06	3.2e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—POMC—autistic disorder	9.41e-06	3.19e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—POMC—autistic disorder	9.26e-06	3.14e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—POMC—autistic disorder	9.24e-06	3.14e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—POMC—autistic disorder	9.21e-06	3.13e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—PTEN—autistic disorder	9.2e-06	3.12e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—POMC—autistic disorder	9.18e-06	3.12e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—POMC—autistic disorder	9.09e-06	3.09e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IGF1—autistic disorder	9.05e-06	3.07e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—MAPK1—autistic disorder	9.01e-06	3.06e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IGF1—autistic disorder	8.91e-06	3.02e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IGF1—autistic disorder	8.89e-06	3.02e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—MAPK1—autistic disorder	8.87e-06	3.01e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IGF1—autistic disorder	8.86e-06	3.01e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—MAPK1—autistic disorder	8.85e-06	3e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IGF1—autistic disorder	8.83e-06	3e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—MAPK1—autistic disorder	8.82e-06	2.99e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—MAPK1—autistic disorder	8.79e-06	2.98e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PTGS2—autistic disorder	8.76e-06	2.97e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IGF1—autistic disorder	8.75e-06	2.97e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—MAPK1—autistic disorder	8.71e-06	2.95e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—SERPINE1—autistic disorder	8.6e-06	2.92e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—SERPINE1—autistic disorder	8.46e-06	2.87e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—SERPINE1—autistic disorder	8.44e-06	2.86e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—SERPINE1—autistic disorder	8.42e-06	2.86e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—SERPINE1—autistic disorder	8.39e-06	2.85e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—SERPINE1—autistic disorder	8.31e-06	2.82e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—HRAS—autistic disorder	8.24e-06	2.8e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—HRAS—autistic disorder	8.2e-06	2.78e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—MAPK1—autistic disorder	8.19e-06	2.78e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—IL2—autistic disorder	7.93e-06	2.69e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—IL6—autistic disorder	7.89e-06	2.68e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—IL2—autistic disorder	7.89e-06	2.68e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—IL6—autistic disorder	7.85e-06	2.66e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PTEN—autistic disorder	7.64e-06	2.59e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—MAPK1—autistic disorder	7.48e-06	2.54e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—PTEN—autistic disorder	7.46e-06	2.53e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—PTEN—autistic disorder	7.42e-06	2.52e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—HRAS—autistic disorder	7.23e-06	2.45e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—HRAS—autistic disorder	7.12e-06	2.42e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—HRAS—autistic disorder	7.1e-06	2.41e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—HRAS—autistic disorder	7.08e-06	2.4e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—HRAS—autistic disorder	7.06e-06	2.39e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—HRAS—autistic disorder	6.99e-06	2.37e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IL2—autistic disorder	6.96e-06	2.36e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—IL6—autistic disorder	6.92e-06	2.35e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IL2—autistic disorder	6.85e-06	2.32e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IL2—autistic disorder	6.83e-06	2.32e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—IL6—autistic disorder	6.81e-06	2.31e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IL2—autistic disorder	6.81e-06	2.31e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—IL6—autistic disorder	6.8e-06	2.31e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IL2—autistic disorder	6.79e-06	2.3e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—IL6—autistic disorder	6.78e-06	2.3e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—IL6—autistic disorder	6.76e-06	2.29e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IL2—autistic disorder	6.72e-06	2.28e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—IL6—autistic disorder	6.69e-06	2.27e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—HRAS—autistic disorder	6.58e-06	2.23e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PTEN—autistic disorder	6.55e-06	2.22e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PTEN—autistic disorder	6.44e-06	2.19e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PTEN—autistic disorder	6.43e-06	2.18e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PTEN—autistic disorder	6.41e-06	2.17e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PTEN—autistic disorder	6.39e-06	2.17e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PTEN—autistic disorder	6.33e-06	2.15e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—IL6—autistic disorder	6.29e-06	2.14e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MAPK1—autistic disorder	6.06e-06	2.06e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MAPK1—autistic disorder	6.03e-06	2.05e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—HRAS—autistic disorder	6e-06	2.04e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—IL6—autistic disorder	5.75e-06	1.95e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MAPK1—autistic disorder	5.32e-06	1.81e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MAPK1—autistic disorder	5.24e-06	1.78e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MAPK1—autistic disorder	5.23e-06	1.77e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MAPK1—autistic disorder	5.21e-06	1.77e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MAPK1—autistic disorder	5.19e-06	1.76e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MAPK1—autistic disorder	5.14e-06	1.74e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—HRAS—autistic disorder	4.87e-06	1.65e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—HRAS—autistic disorder	4.84e-06	1.64e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—IL6—autistic disorder	4.66e-06	1.58e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—IL6—autistic disorder	4.63e-06	1.57e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—HRAS—autistic disorder	4.27e-06	1.45e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—HRAS—autistic disorder	4.21e-06	1.43e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—HRAS—autistic disorder	4.2e-06	1.42e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—HRAS—autistic disorder	4.18e-06	1.42e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—HRAS—autistic disorder	4.17e-06	1.41e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—HRAS—autistic disorder	4.13e-06	1.4e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IL6—autistic disorder	4.09e-06	1.39e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IL6—autistic disorder	4.02e-06	1.37e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IL6—autistic disorder	4.02e-06	1.36e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IL6—autistic disorder	4e-06	1.36e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IL6—autistic disorder	3.99e-06	1.35e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IL6—autistic disorder	3.95e-06	1.34e-05	CbGpPWpGaD
